Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Hidalgo O"" wg kryterium: Autor


Tytuł:
Portal vein thrombosis in a patient with severe hemophilia B: A challenging balanced management.
Autorzy:
Benitez-Hidalgo O; Hematology Department, Hospital Universitari Vall d'Hebron, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO) Vall d'Hebron Barcelona Hospital Campus Barcelona Spain.; Medicine Department Universitat Autònoma de Barcelona Barcelona Spain.
Suito Alcántara M; Hematology Department, Hospital Universitari Vall d'Hebron, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO) Vall d'Hebron Barcelona Hospital Campus Barcelona Spain.; Medicine Department Universitat Autònoma de Barcelona Barcelona Spain.
Martinez Garcia MF; Hematology Department, Hospital Universitari Vall d'Hebron, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO) Vall d'Hebron Barcelona Hospital Campus Barcelona Spain.; Medicine Department Universitat Autònoma de Barcelona Barcelona Spain.
Campoy D; Hematology Department, Hospital Universitari Vall d'Hebron, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO) Vall d'Hebron Barcelona Hospital Campus Barcelona Spain.; Medicine Department Universitat Autònoma de Barcelona Barcelona Spain.
Olivera P; Hematology Department, Hospital Universitari Vall d'Hebron, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO) Vall d'Hebron Barcelona Hospital Campus Barcelona Spain.; Medicine Department Universitat Autònoma de Barcelona Barcelona Spain.
Gironella Mesa M; Hematology Department, Hospital Universitari Vall d'Hebron, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO) Vall d'Hebron Barcelona Hospital Campus Barcelona Spain.; Medicine Department Universitat Autònoma de Barcelona Barcelona Spain.
Juarez-Gimenez JC; Hospital Pharmacy Department Hospital Universitari Vall d'Hebron Barcelona Spain.
Pokaż więcej
Źródło:
Clinical case reports [Clin Case Rep] 2024 Feb 07; Vol. 12 (2), pp. e8121. Date of Electronic Publication: 2024 Feb 07 (Print Publication: 2024).
Typ publikacji:
Case Reports
Raport
Tytuł:
Benefits of rIX-FP prophylaxis in patients with Haemophilia B: real-world evidence from a Spanish reference centre.
Autorzy:
Benítez-Hidalgo O; Servei d'Hematologia, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Barcelona, Spain.; Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain.
Bosch Schips M; Servei d'Hematologia, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Barcelona, Spain.; Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain.
Juárez Giménez JC; Pharmacy Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Gironella M; Servei d'Hematologia, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Barcelona, Spain.; Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2242656.
Typ publikacji:
Journal Article
MeSH Terms:
Hemophilia B*/complications
Hemophilia B*/drug therapy
Humans ; Hemarthrosis
Czasopismo naukowe
Tytuł:
Bioengineering of a Lactococcus lactis subsp. lactis strain enhances nisin production and bioactivity.
Autorzy:
Portieles R; Joint R and D Center of Biotechnology, RETDA, YOTABIO-ENGINEERING CO., LTD., Rizhao, Shandong, P.R. China.
Xu H; Joint R and D Center of Biotechnology, RETDA, YOTABIO-ENGINEERING CO., LTD., Rizhao, Shandong, P.R. China.
Chen F; Joint R and D Center of Biotechnology, RETDA, YOTABIO-ENGINEERING CO., LTD., Rizhao, Shandong, P.R. China.
Gao J; Joint R and D Center of Biotechnology, RETDA, YOTABIO-ENGINEERING CO., LTD., Rizhao, Shandong, P.R. China.
Du L; Joint R and D Center of Biotechnology, RETDA, YOTABIO-ENGINEERING CO., LTD., Rizhao, Shandong, P.R. China.
Gao X; Joint R and D Center of Biotechnology, RETDA, YOTABIO-ENGINEERING CO., LTD., Rizhao, Shandong, P.R. China.
Nordelo CB; ‎VBS Biotec SA, Yuc., México.
Yue Q; State Key Laboratory of Biobased Material and Green Papermaking, Shandong Provincial Key Lab of Microbial Engineering, Qilu University of Technology (Shandong Academic of Science), Jinan, People's Republic of China.
Zhao L; State Key Laboratory of Biobased Material and Green Papermaking, Shandong Provincial Key Lab of Microbial Engineering, Qilu University of Technology (Shandong Academic of Science), Jinan, People's Republic of China.
Gonzalez NP; School of Biological Science and Technology, University of Jinan, Jinan, Shandong, People's Republic of China.
Bermudez RS; School of Biological Science and Technology, University of Jinan, Jinan, Shandong, People's Republic of China.
Borrás-Hidalgo O; Joint R and D Center of Biotechnology, RETDA, YOTABIO-ENGINEERING CO., LTD., Rizhao, Shandong, P.R. China.; State Key Laboratory of Biobased Material and Green Papermaking, Shandong Provincial Key Lab of Microbial Engineering, Qilu University of Technology (Shandong Academic of Science), Jinan, People's Republic of China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Apr 10; Vol. 18 (4), pp. e0281175. Date of Electronic Publication: 2023 Apr 10 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Nisin*/genetics
Nisin*/pharmacology
Lactococcus lactis*/metabolism
Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/metabolism ; Genes, Bacterial ; Bioengineering
Czasopismo naukowe
Tytuł:
Activated prothrombin complex concentrate to treat bleeding events in acquired hemophilia A: BAHAS study.
Autorzy:
Mingot-Castellano ME; Hematology Department, Hospital Universitario Virgen del Rocio, Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Spain.; Hematology Department, Hospital Regional Universitario de Málaga, Málaga, Spain.
García-Candel F; Hematology Department, Hospital Virgen de la Arrixaca, Murcia, Spain.
Benítez-Hidalgo O; Hematology Department, Hospital Vall de Hebron, Barcelona, Spain.
Marco A; Hematology Department, Hospital General de Alicante, Alicante, Spain.
Méndez Navarro GA; Hematology Department, Hospital Marqués de Valdecilla, Santander, Spain.
Pérez-Montes R; Hematology Department, Hospital Marqués de Valdecilla, Santander, Spain.
García Donas G; Hematology Department, Hospital Universitario Virgen Macarena, Sevilla, Spain.
Canaro M; Hematology Department, Hospital Son Espases, Palma de Mallorca, Spain.
Paloma MJ; Hematology Department, Hospital Universitario Virgen del Camino, Pamplona, Spain.
Asenjo B; Hematology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain.
Calle-Gordo VM; Hematology Department, Hospital Torrecárdenas, Almería, Spain.
González NP; Hematology Department, Hospital Torrecárdenas, Almería, Spain.
Rodríguez González R; Hematology Department, Hospital Severo Ochoa, Madrid, Spain.
Caparrón-Miranda IS; Hematology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain.
Quintana París L; Hematology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain.
Herrero S; Hematology Department, Hospital Universitario de Guadalajara, Guadalajara, Spain.
Nuñez R; Hematology Department, Hospital Universitario Virgen del Rocio, Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Spain.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2022 Dec; Vol. 109 (6), pp. 686-695. Date of Electronic Publication: 2022 Sep 12.
Typ publikacji:
Journal Article
MeSH Terms:
Hemophilia A*/complications
Hemophilia A*/drug therapy
Aged ; Humans ; Blood Coagulation Factors/therapeutic use ; Cost-Benefit Analysis ; Factor IX/therapeutic use ; Factor VIII/therapeutic use ; Hemorrhage/etiology ; Hemorrhage/drug therapy ; Recombinant Proteins/therapeutic use
SCR Disease Name:
Factor 8 deficiency, acquired
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies